FIELDS

  • Start- ups ventures
  • In vitro diagnostics
  • Direct to consumer market for diagnostics
  • Online self health applications
  • Infectious diseases
  • Oncology
  • Molecular Diagnostics
  • Medical Diagnostics
  • Simple affordable solutions for emerging markets
  • Neglected Diseases
  • Laboratory automation and workflow
  • International market settings

SERVICES

2M is a strategic partner for start-ups and new medical technologies in the Life Science Industry, in national and international markets. 2M can support in several stages of the life science chain, which begins with a research innovation in one of the life sciences fields and leads to the launch of a fully developed product.

IDEA OR RESEARCH INVENTION: A brilliant novel idea or invention is born In vitro diagnostics, diagnostics, medical device, biomarkers
CONCEPT: In this phase proof of concept experiments are performed to demonstrate the performance of the product.
PRODUCT: The product has been designed and will be validated in a clinical trial. In the meantime the marketing access plan needs to be implemented.
LAUNCH: Validation has been finalized, registrations are in place and it is time to celebrate the launch of a wonderful new medical technology.
SUCCESSFULL PRODUCT: The product now enters a succession of strategies as the product goes through the life cycle, each phase requiring different strategies.

Feedback on viability

Once the research invention or idea has been born 2M Life Sciences can help answer the first important commercially related questions before the proof of concept experiments are designed. Is this a viable product or proposition? The answers to these important questions make sure that the unnecessary investments are not made for a product that is not commercially viable and that the proof of concept results meet the expectations of the proposed customer. To answer the most important question: Is it a sellable product or proposition?

  • Who are the potential customers for the product/proposition?
  • Which need does this product /proposition fulfil?
  • How does this impact clinical management?
  • Can the new technology replace other techniques?
  • What is the (clinical)value of this invention? Define the clinical pathway.
  • Is there enough evidence conduct an early economic analysis?
  • Who else will interact with this product than the primary customer? (Stakeholders)
  • Does the product/proposition fit the needs of the different stakeholders
  • What is the business model?
  • Is it potentially scalable?
  • What are the clear advantages versus competitors?

Other important questions to be answered once a sellable product has been defined:

  • Should the invention be patented?
  • What are the hurdles that need to be taken before launch? (e.g. quality, safety, efficacy, regulatory, reimbursement)
  • What are the fields of expertise essential to the success of the product?
  • How will we access this expertise’s? Hire partnerships or other and is this doable

Based on the answers the next steps can be taken to look for financing for the proof of concept experiments for example: initial business model en plan. If needed 2M Life Sciences can aid in developing these documents and connecting the inventor with potential financing options. Once this is secured the critical specifications for the product or proposition can be defined (see PRODUCT SPECIFICATION) ..